Global Granulocyte Macrophage Colony Stimulating Factor Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Granulocyte Macrophage Colony Stimulating Factor by Country/Region, 2017, 2022 & 2028

2.2 Granulocyte Macrophage Colony Stimulating Factor Segment by Type

2.2.1 CG-0070

2.2.2 Gimsilumab

2.2.3 GSK-3196165

2.2.4 Lenzilumab

2.2.5 MGN-1601

2.2.6 Others

2.3 Granulocyte Macrophage Colony Stimulating Factor Sales by Type

2.3.1 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)

2.3.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Type (2017-2022)

2.3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2017-2022)

2.4 Granulocyte Macrophage Colony Stimulating Factor Segment by Application

2.4.1 Solid Tumor

2.4.2 Lymphoma

2.4.3 Kidney Cancer

2.4.4 Lung Disease

2.4.5 Others

2.5 Granulocyte Macrophage Colony Stimulating Factor Sales by Application

2.5.1 Global Granulocyte Macrophage Colony Stimulating Factor Sale Market Share by Application (2017-2022)

2.5.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue and Market Share by Application (2017-2022)

2.5.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Application (2017-2022)

3 Global Granulocyte Macrophage Colony Stimulating Factor by Company

3.1 Global Granulocyte Macrophage Colony Stimulating Factor Breakdown Data by Company

3.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Company (2020-2022)

3.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2020-2022)

3.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Company (2020-2022)

3.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Company (2020-2022)

3.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2020-2022)

3.3 Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Company

3.4 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Product Location Distribution

3.4.2 Players Granulocyte Macrophage Colony Stimulating Factor Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region

4.1 World Historic Granulocyte Macrophage Colony Stimulating Factor Market Size by Geographic Region (2017-2022)

4.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Geographic Region

4.2 World Historic Granulocyte Macrophage Colony Stimulating Factor Market Size by Country/Region (2017-2022)

4.2.1 Global Granulocyte Macrophage Colony Stimulating Factor Annual Sales by Country/Region (2017-2022)

4.2.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue by Country/Region

4.3 Americas Granulocyte Macrophage Colony Stimulating Factor Sales Growth

4.4 APAC Granulocyte Macrophage Colony Stimulating Factor Sales Growth

4.5 Europe Granulocyte Macrophage Colony Stimulating Factor Sales Growth

4.6 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Growth

5 Americas

5.1 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country

5.1.1 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022)

5.1.2 Americas Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022)

5.2 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Type

5.3 Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region

6.1.1 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2017-2022)

6.1.2 APAC Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2017-2022)

6.2 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Type

6.3 APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Granulocyte Macrophage Colony Stimulating Factor by Country

7.1.1 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022)

7.1.2 Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022)

7.2 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type

7.3 Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor by Country

8.1.1 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022)

8.1.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022)

8.2 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type

8.3 Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor

10.3 Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor

10.4 Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Granulocyte Macrophage Colony Stimulating Factor Distributors

11.3 Granulocyte Macrophage Colony Stimulating Factor Customer

12 World Forecast Review for Granulocyte Macrophage Colony Stimulating Factor by Geographic Region

12.1 Global Granulocyte Macrophage Colony Stimulating Factor Market Size Forecast by Region

12.1.1 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Region (2023-2028)

12.1.2 Global Granulocyte Macrophage Colony Stimulating Factor Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Type

12.7 Global Granulocyte Macrophage Colony Stimulating Factor Forecast by Application

13 Key Players Analysis

13.1 Aduro BioTech Inc

13.1.1 Aduro BioTech Inc Company Information

13.1.2 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.1.3 Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Aduro BioTech Inc Main Business Overview

13.1.5 Aduro BioTech Inc Latest Developments

13.2 Amgen Inc

13.2.1 Amgen Inc Company Information

13.2.2 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.2.3 Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Amgen Inc Main Business Overview

13.2.5 Amgen Inc Latest Developments

13.3 BriaCell Therapeutics Corp

13.3.1 BriaCell Therapeutics Corp Company Information

13.3.2 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.3.3 BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 BriaCell Therapeutics Corp Main Business Overview

13.3.5 BriaCell Therapeutics Corp Latest Developments

13.4 Cold Genesys Inc

13.4.1 Cold Genesys Inc Company Information

13.4.2 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.4.3 Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Cold Genesys Inc Main Business Overview

13.4.5 Cold Genesys Inc Latest Developments

13.5 GlaxoSmithKline Plc

13.5.1 GlaxoSmithKline Plc Company Information

13.5.2 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.5.3 GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKline Plc Main Business Overview

13.5.5 GlaxoSmithKline Plc Latest Developments

13.6 Humanigen Inc

13.6.1 Humanigen Inc Company Information

13.6.2 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.6.3 Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Humanigen Inc Main Business Overview

13.6.5 Humanigen Inc Latest Developments

13.7 Mologen AG

13.7.1 Mologen AG Company Information

13.7.2 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.7.3 Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mologen AG Main Business Overview

13.7.5 Mologen AG Latest Developments

13.8 Morphotek Inc

13.8.1 Morphotek Inc Company Information

13.8.2 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.8.3 Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Morphotek Inc Main Business Overview

13.8.5 Morphotek Inc Latest Developments

13.9 Sillajen Biotherapeutics

13.9.1 Sillajen Biotherapeutics Company Information

13.9.2 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.9.3 Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sillajen Biotherapeutics Main Business Overview

13.9.5 Sillajen Biotherapeutics Latest Developments

13.10 Takeda Pharmaceutical Co Ltd

13.10.1 Takeda Pharmaceutical Co Ltd Company Information

13.10.2 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Offered

13.10.3 Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Takeda Pharmaceutical Co Ltd Main Business Overview

13.10.5 Takeda Pharmaceutical Co Ltd Latest Developments

14 Research Findings and Conclusion

Table 1. Granulocyte Macrophage Colony Stimulating Factor Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Granulocyte Macrophage Colony Stimulating Factor Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of CG-0070

Table 4. Major Players of Gimsilumab

Table 5. Major Players of GSK-3196165

Table 6. Major Players of Lenzilumab

Table 7. Major Players of MGN-1601

Table 8. Major Players of Others

Table 9. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)

Table 10. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)

Table 11. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Type (2017-2022) & ($ million)

Table 12. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2017-2022)

Table 13. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Type (2017-2022) & (USD/Pcs)

Table 14. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)

Table 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)

Table 16. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Application (2017-2022)

Table 17. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application (2017-2022)

Table 18. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Application (2017-2022) & (USD/Pcs)

Table 19. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Company (2020-2022) & (K Pcs)

Table 20. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Company (2020-2022)

Table 21. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company (2020-2022)

Table 23. Global Granulocyte Macrophage Colony Stimulating Factor Sale Price by Company (2020-2022) & (USD/Pcs)

Table 24. Key Manufacturers Granulocyte Macrophage Colony Stimulating Factor Producing Area Distribution and Sales Area

Table 25. Players Granulocyte Macrophage Colony Stimulating Factor Products Offered

Table 26. Granulocyte Macrophage Colony Stimulating Factor Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Geographic Region (2017-2022) & (K Pcs)

Table 30. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Geographic Region (2017-2022)

Table 31. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales by Country/Region (2017-2022) & (K Pcs)

Table 34. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country/Region (2017-2022)

Table 35. Global Granulocyte Macrophage Colony Stimulating Factor Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)

Table 38. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)

Table 39. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)

Table 41. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)

Table 42. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)

Table 43. Americas Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)

Table 44. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)

Table 45. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2017-2022) & (K Pcs)

Table 46. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)

Table 47. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Region (2017-2022)

Table 49. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)

Table 50. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)

Table 51. APAC Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)

Table 52. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)

Table 53. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)

Table 54. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)

Table 55. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)

Table 57. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)

Table 58. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)

Table 59. Europe Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)

Table 60. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Country (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Type (2017-2022) & (K Pcs)

Table 66. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales by Application (2017-2022) & (K Pcs)

Table 68. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Granulocyte Macrophage Colony Stimulating Factor

Table 70. Key Market Challenges & Risks of Granulocyte Macrophage Colony Stimulating Factor

Table 71. Key Industry Trends of Granulocyte Macrophage Colony Stimulating Factor

Table 72. Granulocyte Macrophage Colony Stimulating Factor Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Granulocyte Macrophage Colony Stimulating Factor Distributors List

Table 75. Granulocyte Macrophage Colony Stimulating Factor Customer List

Table 76. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 77. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Forecast by Region

Table 78. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Region (2023-2028) & (K Pcs)

Table 83. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 85. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Country (2023-2028) & (K Pcs)

Table 87. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Type (2023-2028) & (K Pcs)

Table 89. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Granulocyte Macrophage Colony Stimulating Factor Sales Forecast by Application (2023-2028) & (K Pcs)

Table 93. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share Forecast by Application (2023-2028)

Table 96. Aduro BioTech Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 97. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 98. Aduro BioTech Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 99. Aduro BioTech Inc Main Business

Table 100. Aduro BioTech Inc Latest Developments

Table 101. Amgen Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 102. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 103. Amgen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 104. Amgen Inc Main Business

Table 105. Amgen Inc Latest Developments

Table 106. BriaCell Therapeutics Corp Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 107. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 108. BriaCell Therapeutics Corp Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 109. BriaCell Therapeutics Corp Main Business

Table 110. BriaCell Therapeutics Corp Latest Developments

Table 111. Cold Genesys Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 112. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 113. Cold Genesys Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 114. Cold Genesys Inc Main Business

Table 115. Cold Genesys Inc Latest Developments

Table 116. GlaxoSmithKline Plc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 117. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 118. GlaxoSmithKline Plc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 119. GlaxoSmithKline Plc Main Business

Table 120. GlaxoSmithKline Plc Latest Developments

Table 121. Humanigen Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 122. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 123. Humanigen Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 124. Humanigen Inc Main Business

Table 125. Humanigen Inc Latest Developments

Table 126. Mologen AG Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 127. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 128. Mologen AG Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 129. Mologen AG Main Business

Table 130. Mologen AG Latest Developments

Table 131. Morphotek Inc Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 132. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 133. Morphotek Inc Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 134. Morphotek Inc Main Business

Table 135. Morphotek Inc Latest Developments

Table 136. Sillajen Biotherapeutics Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 137. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 138. Sillajen Biotherapeutics Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 139. Sillajen Biotherapeutics Main Business

Table 140. Sillajen Biotherapeutics Latest Developments

Table 141. Takeda Pharmaceutical Co Ltd Basic Information, Granulocyte Macrophage Colony Stimulating Factor Manufacturing Base, Sales Area and Its Competitors

Table 142. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Product Offered

Table 143. Takeda Pharmaceutical Co Ltd Granulocyte Macrophage Colony Stimulating Factor Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 144. Takeda Pharmaceutical Co Ltd Main Business

Table 145. Takeda Pharmaceutical Co Ltd Latest Developments

List of Figures

Figure 1. Picture of Granulocyte Macrophage Colony Stimulating Factor

Figure 2. Granulocyte Macrophage Colony Stimulating Factor Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Granulocyte Macrophage Colony Stimulating Factor Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Granulocyte Macrophage Colony Stimulating Factor Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of CG-0070

Figure 10. Product Picture of Gimsilumab

Figure 11. Product Picture of GSK-3196165

Figure 12. Product Picture of Lenzilumab

Figure 13. Product Picture of MGN-1601

Figure 14. Product Picture of Others

Figure 15. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Type in 2021

Figure 16. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Type (2017-2022)

Figure 17. Granulocyte Macrophage Colony Stimulating Factor Consumed in Solid Tumor

Figure 18. Global Granulocyte Macrophage Colony Stimulating Factor Market: Solid Tumor (2017-2022) & (K Pcs)

Figure 19. Granulocyte Macrophage Colony Stimulating Factor Consumed in Lymphoma

Figure 20. Global Granulocyte Macrophage Colony Stimulating Factor Market: Lymphoma (2017-2022) & (K Pcs)

Figure 21. Granulocyte Macrophage Colony Stimulating Factor Consumed in Kidney Cancer

Figure 22. Global Granulocyte Macrophage Colony Stimulating Factor Market: Kidney Cancer (2017-2022) & (K Pcs)

Figure 23. Granulocyte Macrophage Colony Stimulating Factor Consumed in Lung Disease

Figure 24. Global Granulocyte Macrophage Colony Stimulating Factor Market: Lung Disease (2017-2022) & (K Pcs)

Figure 25. Granulocyte Macrophage Colony Stimulating Factor Consumed in Others

Figure 26. Global Granulocyte Macrophage Colony Stimulating Factor Market: Others (2017-2022) & (K Pcs)

Figure 27. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Application (2017-2022)

Figure 28. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Application in 2021

Figure 29. Granulocyte Macrophage Colony Stimulating Factor Revenue Market by Company in 2021 ($ Million)

Figure 30. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Company in 2021

Figure 31. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Geographic Region (2017-2022)

Figure 32. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Geographic Region in 2021

Figure 33. Global Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region (2017-2022)

Figure 34. Global Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country/Region in 2021

Figure 35. Americas Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)

Figure 36. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 37. APAC Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)

Figure 38. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 39. Europe Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)

Figure 40. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 41. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales 2017-2022 (K Pcs)

Figure 42. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue 2017-2022 ($ Millions)

Figure 43. Americas Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2021

Figure 44. Americas Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2021

Figure 45. United States Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 46. Canada Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 47. Mexico Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 48. Brazil Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 49. APAC Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Region in 2021

Figure 50. APAC Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Regions in 2021

Figure 51. China Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 52. Japan Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 53. South Korea Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 54. Southeast Asia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 55. India Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 56. Australia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 57. Europe Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2021

Figure 58. Europe Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2021

Figure 59. Germany Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 60. France Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 61. UK Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 62. Italy Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 63. Russia Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 64. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Sales Market Share by Country in 2021

Figure 65. Middle East & Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Market Share by Country in 2021

Figure 66. Egypt Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 67. South Africa Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 68. Israel Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 69. Turkey Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 70. GCC Country Granulocyte Macrophage Colony Stimulating Factor Revenue Growth 2017-2022 ($ Millions)

Figure 71. Manufacturing Cost Structure Analysis of Granulocyte Macrophage Colony Stimulating Factor in 2021

Figure 72. Manufacturing Process Analysis of Granulocyte Macrophage Colony Stimulating Factor

Figure 73. Industry Chain Structure of Granulocyte Macrophage Colony Stimulating Factor

Figure 74. Channels of Distribution

Figure 75. Distributors Profiles